HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sassoon/P&G case to proceed

This article was originally published in The Rose Sheet

Executive Summary

Trial is scheduled to commence Sept. 21, 2004, following Oct. 20 denial by Los Angeles federal judge of Procter & Gamble's motion to dismiss Vidal Sassoon lawsuit against P&G alleging breach of fiduciary duty and constructive fraud. Judge notes that Sassoon adequately alleged claims of constructive fraud, existence of fiduciary relationship between firms. Ruling maintains Sassoon has not sufficiently supported fraud; however claim may be refiled with more specific references alleging justifiable reliance or damages. Sassoon seeking "hundreds of millions of dollars in damages" in addition to termination of licensing agreement with P&G, attorneys for hair stylist note. Complaint filed in April claimed P&G neglected Sassoon's namesake brand of hair care products in favor of brands such as Pantene (1"The Rose Sheet" April 7, 2003, p. 6)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011622

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel